Dis Semin. Liver . .. , 37 : 1-10.
Sun M.,Kisseleva T. .2015 .Reversibility ofliver fibrosis. , : .
Hepatol Clin. Res. . .. , 39 : S60-563.
Venturi C,Bourdeaux C.,Hoyos S.P. .2014 .Dynamofialclogsraft fibrosis in pediatric liver transplantation. Am. J. Transpl., 14 : 1648-1656.
Hermansyah D,K. D .2021 .Mesenchymal stem cells suppress TGF-B release to decrease a-SMA expression in ameliorating CCl4-inldiveur cfiebrodsis. Med, 75 : 16-22.
Sungkar T,Putra A.,D. A. .2020 .Lindarto and RJ. , : .
T. ,Putra A.,D. A.,Garcia-Sanchez D.,Fernandez D.,Rodriguez-Rey J.C.,Pérez-Campo F.M.,Y. F.M.,Tsuchiya A.,Ogawa M.,Nojiri S.,Takeuchi S.,D.M. S.,Munir D.,Putra D. .2022 .Revealing the decrease of indoleamine 2,3-dioxygenase as a major constituent for B cells survival post-mesenchymal stem cells co-cultured with peripheral blood mononuclear cells (PBMC) of systemic lupus erythematosus (SLE) patients. Medicinski Glasnik, 19 : 1414-21.
. Drawina P,Putra A.,Nasihun T.,Prajoko Y.W.,Dirja B.T.,Amalina N.D. .2022 .Increased serial levels of platelet-derived growth factor using hypoxic mesenchymal stem cell-conditioned medium to promote closure acceler-ationin a full-thickness wound. Indones. J. Biotechnol, 27 : 36-42.
. Putra A,Alif I,Hamra N.,Santosa O.,Lukman K. .2020 .MSC-released TGF-B regulate a-SMA expression of myofibroblast during wound healing. J. Stem Cells Regener. Med, 16 : 73-79.
Kwon B.S. .2017 .Differentiation potential of mesenchymal stem cells is related to their intrinsic mechanical properties. Int. Neurourol.J., 21 : 524-31.
. Restimulia L,Ghaissani S.S.,Haryono E. .2022 .Downregulation of IL-6 and TNF-a expression with mesenchymal stem cells therapy inallergicrhinitriasts models. Int.J. Cell Biomed. Sci, 1 : 27-34.
NF ,Putra A.,Tjipta A,Amalina N.D.,Nasihun T. .2021 .Hypoxia mesenchymal stem cells accelerate wound closure improvement by controlling a-smooth muscle actin expression in the full-thickness animal model. Open Access Maced. J. Med. Sci., 9 : 35-41.
YW ,Amalina N.D. .2022 .The ameliorating effects of MSCs in controlling treg-mediated B-cell depletion byindoleamine2, 3-dioxygenase induction in PBMC of SLE patients. Open Access Maced. J. Med. Sci., 10 : 6-11.
. Chacko S.,Selvendiran K.,Kuppusamy M.L.,Khan M.,Kuppusamy P. .2010 .Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells. Am. J. Physiol. Cell Physiol, 299 : C1562-C1570.
Yao Y.,Xia Z. .2021 .Human placental mesenchymal stem cells ameli olivrerafitbreosis in mice by upregulation of Caveolin1 in hepatic stellate cells. He et a/, : .
Stem Cell Res. Ther. . .. , 12 : 513287.
Rong X,Yao X.,Jiang T.,Wang Y.,Xie F. .2019 .. , : .
. .Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/B-catenin pathway. Stem Cell Res. Ther, 10 : .
M.A ,Subchan P.,Handoyo F.E.,Husain S.A. .2022 .Topical gel of mesenchymal stem cell-conditioned medium-induced serum injury accelerates wound healing in skin excision tissue. Int.J. Cell Biomed. Sci., 1 : 10-17.
Putra A,Widyatmoko A.,Ibrahim S.,Amansyah F.,Amansyah F. .2021 .Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal ~ stem cells in Indonesia.. , : .
. .. F1000Research, 10 : .
Putra A,Pasongka Z,Widyatmoko A.,Prasetio A.,Dirja B.T. .2022 .X-ray scanning reduce soluble active mole cofumeslenechysmal stem cells. In tJ. .Cell Biomed. Sci., 1 : 35-40.
Zhang ,D. Zhou J.,Li X.,Yan J.,Zhu J. .2019 .Effects ofbone marrow-derived mesenchymal stem cells on hypoxia and the transforming growth factor beta 1 (TGFB-1) and SMADs pathway in a mouse model of cirrhosis. Med, : .
Monit . .. , 25 : 7182-7190.
Huang B.,Wang W. .2016 .Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively. J. Transl. Med, 14 : 512967.
Liu S.C.,Hung W.C.,Chen H.,Zhang H. .2017 .Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusioninduced lung injury. PLoS ONE, 0187637 : .
Nakamura S.,Mizuno S. .2010 .The discovery of hepatocyte growth factor (HGF) and its significance for cell biology, life sciences and clinical medicine. Proc. Jpn. Acad. Ser. B, 86 : 588-610.
Elpek G.O. .2015 .Angiogenesis and liver fibrosis. World J. Hepatol, 7 : 377-391.
D ,Berthiaume F.,Nahmias Y.,A.W.Tillesand M.L. Yarmush Y. .2008 .Mesenchymal stem cell-derived moleculemsodduliater ehepcattocelllyular death and regeneration /n vitro and in vivo. Hepatology, 47 : 1634-1643.
Zhu Y,Zhang X.,Zhu J.,Zhao Q.,Li Y. .2012 .Cytotoxicity of phenol red in toxicity assays for carbon nanopInta. J. rMol.tScii,Vocl. 1l3.1e0.3s390./ijms131012336., : .
Liu X,Chen B.,Chen L,Ren W.T. .2013 .U-shape suppressive effect of phenol red on the epileptiform burst activity via activation of estrogen receptors in primary hippocampal =~ culture. PLoS ONE, 0060189 : .
Gyorfi AH .2018 .Targeting TGF- signaling for the treatment of fibrosis. Matrix Biol, : 8-27.
Dai H.Y.,Li G.,Ritchie J.X.,Zhou J.X. .2009 .The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis. Stem Cell Res, 2 : 16-25.